Canton Hathaway’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $1.53M | Hold |
2,271
| – | – | 0.3% | 43 |
|
|
2026
Q2 | $1.14M | Hold |
2,271
| – | – | 0.22% | 56 |
|
|
2026
Q1 | $1.12M | Hold |
2,271
| – | – | 0.23% | 55 |
|
|
2025
Q4 | $1.32M | Hold |
2,271
| – | – | 0.25% | 48 |
|
|
2025
Q3 | $1.1M | Hold |
2,271
| – | – | 0.21% | 56 |
|
|
2025
Q2 | $921K | Hold |
2,271
| – | – | 0.19% | 60 |
|
|
2025
Q1 | $1.13M | Buy |
2,271
+1,200
| +112% | +$650K | 0.23% | 49 |
|
|
2024
Q4 | $557K | Hold |
1,071
| – | – | 0.14% | 57 |
|
|
2024
Q3 | $662K | Hold |
1,071
| – | – | 0.17% | 54 |
|
|
2024
Q2 | $592K | Hold |
1,071
| – | – | 0.16% | 57 |
|
|
2024
Q1 | $622K | Hold |
1,071
| – | – | 0.17% | 54 |
|
|
2023
Q4 | $568K | Hold |
1,071
| – | – | 0.17% | 54 |
|
|
2023
Q3 | $542K | Sell |
1,071
-21
| -2% | -$11.2K | 0.17% | 53 |
|
|
2023
Q2 | $570K | Hold |
1,092
| – | – | 0.18% | 52 |
|
|
2023
Q1 | $629K | Hold |
1,092
| – | – | 0.21% | 50 |
|
|
2022
Q4 | $601K | Hold |
1,092
| – | – | 0.21% | 52 |
|
|
2022
Q3 | $554K | Hold |
1,092
| – | – | 0.2% | 60 |
|
|
2022
Q2 | $593K | Hold |
1,092
| – | – | 0.21% | 59 |
|
|
2022
Q1 | $645K | Sell |
1,092
-83
| -7% | -$47.7K | 0.18% | 62 |
|
|
2021
Q4 | $784K | Hold |
1,175
| – | – | 0.21% | 61 |
|
|
2021
Q3 | $671K | Buy |
1,175
+98
| +9% | +$53.8K | 0.19% | 69 |
|
|
2021
Q2 | $543K | Buy |
1,077
+166
| +18% | +$78.3K | 0.16% | 70 |
|
|
2021
Q1 | $416K | Buy |
911
+70
| +8% | +$33.4K | 0.13% | 78 |
|
|
2020
Q4 | $392K | Buy |
841
+40
| +5% | +$18.8K | 0.13% | 80 |
|
|
2020
Q3 | $354K | Hold |
801
| – | – | 0.15% | 64 |
|
|
2020
Q2 | $290K | Hold |
801
| – | – | 0.19% | 59 |
|
|
2020
Q1 | $227K | Sell |
801
-245
| -23% | -$77.3K | 0.16% | 57 |
|
|
2019
Q4 | $340K | Buy |
1,046
+150
| +17% | +$45.5K | 0.17% | 63 |
|
|
2019
Q3 | $261K | Buy |
896
+83
| +10% | +$23.8K | 0.14% | 71 |
|
|
2019
Q2 | $239K | Sell |
813
-340
| -29% | -$93.6K | 0.13% | 75 |
|
|
2019
Q1 | $315K | Buy |
1,153
+663
| +135% | +$165K | 0.18% | 56 |
|
|
2018
Q4 | $110K | Buy |
490
+235
| +92% | +$55.1K | 0.07% | 87 |
|
|
2018
Q3 | $62K | Buy |
+255
| New | +$58.7K | 0.04% | 92 |
|
Other funds holding TMO
Canton Hathaway's TMO Position: Q3 2026 in Review
Canton Hathaway held its Thermo Fisher Scientific (TMO) position steady in Q3 2026 at 2,271 shares worth $1.53M. The position accounts for 0.3% of the portfolio, ranked #43.
Canton Hathaway first reported a position in TMO in Q3 2018 and has held it in 33 quarters since. 2,450 funds tracked by Wall St. Rank hold TMO as of Q3 2026.
- Canton Hathaway held 2,271 shares of Thermo Fisher Scientific worth $1.53M as of Q3 2026.
- Canton Hathaway left its Thermo Fisher Scientific share count unchanged in Q3 2026.
- Thermo Fisher Scientific made up 0.3% of Canton Hathaway's portfolio in Q3 2026, its #43 holding.
- Canton Hathaway first reported a position in Thermo Fisher Scientific in Q3 2018 and has held it in 33 quarters since.
- 2,450 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.
Based on Canton Hathaway's 13F filing for Q3 2026, filed 23 Oct 2026.